Evonik stock gains 1.06 percent after BASF bid rejection

Published on 09/30/2026 at 10:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

BASF reportedly offered EUR 22.15 per Evonik share before the approach was rejected. Q2 adjusted EBITDA reached EUR 630 million, up 24.00 percent year over year.

Fotorealistisches Luftbild eines Spezialchemiewerks mit Destillationstürmen bei Sonnenuntergang — Evonik Industries DE000EVNK013 zeigt ein fotorealistisches Luftbild eines großen Spezialchemiewerks bei Abenddämmerung, Illustration mit AI erstellt.

Evonik (ISIN DE000EVNK013) stock was trading at EUR 20.06 at Lang & Schwarz on September 30, 2026 at 10:51 a.m. CEST, up 1.06 percent versus the prior close of EUR 19.85. Reuters reported on September 28, 2026, that Evonik rejected a BASF takeover bid valued at EUR 10.3 billion as too low.

BASF offer stays below the mark

The reported proposal was EUR 22.15 per Evonik share, compared with the EUR 19.85 prior close at Lang & Schwarz on September 29, 2026. The offer figure is therefore above the current euro quote, while the rejection keeps the potential transaction dependent on a materially different approach.

EQS News reported Evonik's September 25, 2026 statement that BASF had submitted a non-binding approach for all shares. Evonik described the approach as non-binding and limited further comment to its legal obligations.

Quarterly earnings add a second driver

The takeover story meets an improved operating backdrop. In the Q2 2026 earnings call, Yahoo Finance reported that adjusted EBITDA rose 24.00 percent year over year to EUR 630 million. Management attributed the increase to higher volumes and prices, each contributing 7.00 percent.

The next scheduled checkpoint is November 3, 2026, when Evonik plans to report its Q3 2026 performance, according to the company's investor-relations calendar. That date matters because the second-quarter call described the third quarter as another period of strength before a possible normalization later in the year.

Evonik stock approaches yearly high

Evonik's EUR 20.06 quote is 0.89 percent below the 52-week high of EUR 20.24 and above the 52-week low of EUR 12.49. Market capitalization stood at EUR 9.3 billion on September 30, 2026, while the stock's 1.06 percent intraday gain keeps the market reaction aligned with the takeover premium under discussion.